Neurointerventional Device

Neurointerventional Device Market Outlook

The global neurointerventional device market is projected to reach approximately USD 3.5 billion by the year 2035, growing at a remarkable compound annual growth rate (CAGR) of around 8.3% during the forecast period from 2025 to 2035. This significant growth is attributed to the rising prevalence of neurological disorders and the increased adoption of minimally invasive surgeries, which are driving demand for advanced neurointerventional products. Additionally, technological advancements in neuroimaging and the development of sophisticated devices are providing neurosurgeons with enhanced tools for effective diagnosis and treatment. The growing geriatric population, who are at a higher risk of neurovascular diseases, is also a critical factor contributing to the market expansion. Furthermore, the increasing investments in healthcare infrastructure and research activities are expected to bolster the neurointerventional device market.

Growth Factor of the Market

The neurointerventional device market is experiencing robust growth, driven by several key factors that are shaping the landscape of neurological healthcare. Firstly, the rising incidence of cerebrovascular diseases, such as aneurysms and strokes, is leading to a higher demand for neurointerventional procedures. As healthcare professionals seek innovative solutions to manage these conditions effectively, the market for specialized devices is expanding rapidly. Furthermore, advancements in minimally invasive techniques are significantly improving patient outcomes, resulting in shorter recovery times and reduced hospital stays. Secondly, the increasing awareness among patients regarding the benefits of neurointerventional therapies is prompting more individuals to seek treatment. Thirdly, the growing number of specialized healthcare facilities and clinics equipped with state-of-the-art neurointerventional technologies is enhancing accessibility to these solutions. Moreover, strategic collaborations between device manufacturers and hospitals are facilitating the development and distribution of cutting-edge products, further driving market growth. Lastly, growing support from regulatory bodies and increasing reimbursement options are creating a favorable environment for the adoption of neurointerventional devices.

Key Highlights of the Market

• The neurointerventional device market is projected to exceed USD 3.5 billion by 2035.
• Technological advancements in neuroimaging are enhancing treatment outcomes.
• Minimally invasive procedures are becoming the preferred choice for patients.
• The geriatric population is driving the demand for neurovascular treatments.
• Regulatory support and favorable reimbursement policies are boosting market growth.

By Product Type

Embolization Coils:

Embolization coils represent one of the most crucial segments in the neurointerventional device market, primarily used for the treatment of cerebral aneurysms and arteriovenous malformations (AVMs). These coils are designed to occlude blood vessels, effectively preventing blood flow to specific areas, thus reducing the risk of rupture and associated complications. The market for embolization coils is witnessing significant growth due to the increasing incidence of these conditions and the rising preference for minimally invasive techniques among healthcare professionals. Additionally, continuous innovations in coil design, including bioactive and detachable coils, are enhancing their effectiveness and safety profiles. As a result, embolization coils are gaining traction within hospitals and specialty clinics, thereby driving overall market growth.

Neurovascular Stents:

Neurovascular stents are another vital product type within the neurointerventional device market. These devices are utilized to support and maintain the patency of occluded or narrowed blood vessels in the brain, facilitating improved blood flow. The growing prevalence of ischemic strokes and transient ischemic attacks (TIAs) is significantly boosting the demand for neurovascular stents. Innovations in stent design, such as the development of bioresorbable stents, are enhancing their functionality and minimizing the risk of complications. The market for neurovascular stents is steadily expanding, driven by advances in interventional radiology techniques and improved patient outcomes associated with stenting procedures. Furthermore, the increasing number of clinical trials and research efforts focusing on innovative stenting solutions is expected to contribute to market growth in the coming years.

Microcatheters:

Microcatheters are specialized devices essential for delivering therapeutic agents, such as embolization coils and stents, to targeted brain areas during neurointerventional procedures. The increasing demand for precise and targeted treatments is propelling the microcatheter market forward. These devices are characterized by their small diameter and flexibility, allowing for access to complex vascular structures in the brain. As techniques in neurointervention evolve, the need for high-quality microcatheters with enhanced navigation capabilities and compatibility with various interventional tools is growing. The rising incidence of neurovascular diseases and the growing trend toward minimally invasive procedures further drive the demand for microcatheters, as they play a crucial role in improving procedural success rates and patient outcomes.

Flow Diverters:

Flow diverters are advanced devices designed to redirect blood flow away from aneurysms, allowing for the natural healing and remodeling of affected vessels. The increasing adoption of flow diversion technology is transforming the management of complex neurovascular conditions, particularly in challenging anatomies. The market for flow diverters is expanding as healthcare providers recognize their potential to improve treatment outcomes and reduce the risks associated with traditional procedures. Ongoing research and product development aimed at enhancing the efficacy and safety of flow diverters are further contributing to market growth. As more hospitals and specialized centers invest in these innovative devices, the utilization of flow diverters is expected to increase significantly in the upcoming years.

Neurovascular Thrombectomy Devices:

Neurovascular thrombectomy devices are critical in the management of acute ischemic stroke, enabling the removal of blood clots from occluded cerebral vessels. The growing incidence of strokes and the urgent need for effective treatments have significantly increased the demand for these devices. Advances in thrombectomy technology, including the development of retrievable stents and aspiration catheters, are enhancing procedural success rates and improving patient outcomes. The neurovascular thrombectomy market is witnessing substantial growth due to the increasing awareness of stroke management techniques and the emphasis on timely interventions. Furthermore, collaborations between device manufacturers and healthcare institutions are facilitating the adoption of these technologies, thereby driving market expansion.

By Application

Hospitals:

Hospitals are the primary application segment for neurointerventional devices, serving as the major settings for diagnosing and treating neurological disorders. With advanced facilities and specialized staff, hospitals are equipped to perform complex neurointerventional procedures, driving the demand for innovative devices. The rising prevalence of neurological diseases and the need for immediate medical attention, especially in emergency cases like strokes, are further escalating the demand in hospital settings. Moreover, the increasing number of specialized neurointerventional units within hospitals is expected to enhance the adoption of these devices, contributing to market growth. As hospitals invest in cutting-edge technologies, the integration of advanced neurointerventional devices into routine practice is anticipated to improve treatment outcomes and patient safety.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as significant players in the neurointerventional device market, providing a cost-effective alternative to traditional hospital settings for various procedures. The increasing number of ASCs specializing in neurointerventions is attributed to the rising demand for outpatient surgeries, including minimally invasive treatments for neurological conditions. ASCs offer the advantages of shorter wait times, reduced healthcare costs, and improved patient experiences, making them an attractive option for patients undergoing neurointerventional procedures. The growing focus on enhancing access to care and improving patient outcomes is further driving the demand for neurointerventional devices in ASCs, as they adopt advanced technologies to deliver effective treatments.

Specialty Clinics:

Specialty clinics play a crucial role in providing focused care for patients with specific neurological conditions, driving the demand for neurointerventional devices. These clinics often have specialized expertise in neurovascular diseases, enabling them to offer targeted treatments that are tailored to individual patient needs. The increasing number of specialty clinics dedicated to neurointervention is contributing to the growing market, as more patients seek specialized care. Moreover, the rise of multidisciplinary approaches in treating neurological disorders within specialty clinics is enhancing the efficacy of neurointerventional procedures. As patients become more informed about the availability of specialized care options, the demand for neurointerventional devices in these settings is expected to rise significantly.

Others:

The "Others" segment encompasses various healthcare facilities and settings where neurointerventional devices are utilized, including research institutions and rehabilitation centers. This segment is gaining traction as the awareness of neurointerventional procedures expands beyond traditional healthcare settings. Research institutions play a significant role in the development and evaluation of new neurointerventional devices, driving innovation in the field. Rehabilitation centers also contribute to the market by employing neurointerventional techniques to aid patients recovering from neurological conditions. As these diverse settings increasingly adopt neurointerventional devices, the overall market for these products is expected to experience continued growth.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies serve as a primary distribution channel for neurointerventional devices, providing essential supplies for surgical procedures. The centralized procurement process in hospitals ensures that a wide range of neurointerventional products is readily available for use in various departments. The high volume of procedures conducted in hospitals leads to a consistent demand for these devices, driving market growth through hospital pharmacies. Additionally, as hospitals increasingly adopt advanced technologies, the integration of neurointerventional devices into their procurement strategies is expected to enhance product availability, thereby supporting the growth of this distribution channel.

Retail Pharmacies:

Retail pharmacies are also emerging as a distribution channel for neurointerventional devices, although their market share is comparatively smaller than that of hospital pharmacies. The growing trend of outpatient care and patient empowerment is driving an increase in the demand for neurointerventional products in retail settings. Retail pharmacies often cater to patients seeking post-procedure supplies or educational resources related to neurointerventional treatments. As awareness of neurovascular diseases continues to rise, retail pharmacies are evolving to accommodate patient needs, thus contributing to the overall market for neurointerventional devices.

Online Pharmacies:

Online pharmacies are revolutionizing the distribution of neurointerventional devices by offering convenient access to a range of products. The increasing prevalence of e-commerce in the healthcare sector is driving the growth of online pharmacies, which allow patients and healthcare professionals to purchase neurointerventional devices from the comfort of their homes. This distribution channel provides an extensive array of products, often at competitive prices, attracting both individual consumers and medical facilities. The flexibility and accessibility of online pharmacies are enhancing the overall market for neurointerventional devices as they become more integrated into patients' healthcare journeys.

Others:

The "Others" category includes various alternative distribution channels for neurointerventional devices, such as direct sales by manufacturers and third-party distributors. These channels play a vital role in ensuring that a diverse range of products reaches healthcare facilities and professionals. Direct sales allow manufacturers to establish strong relationships with healthcare providers, facilitating tailored solutions that meet specific needs. Additionally, third-party distributors enhance market reach by connecting manufacturers with a broader customer base. As the neurointerventional device market continues to grow, these alternative distribution channels are expected to play an increasingly important role in product availability and accessibility.

By Material Type

Metallic:

Metallic materials are widely utilized in the manufacturing of neurointerventional devices due to their strength, durability, and biocompatibility. Devices such as embolization coils and stents often incorporate metals like stainless steel and platinum, which provide the necessary structural integrity for effective performance. The demand for metallic neurointerventional devices is growing due to their proven efficacy in various applications, including the treatment of aneurysms and vascular malformations. Innovations in metallic materials, such as the development of magnetically controlled devices, are further enhancing their functionality. As healthcare providers increasingly opt for reliable and effective treatment options, the market for metallic neurointerventional devices is expected to expand significantly.

Polymer:

Polymer materials are gaining popularity in the neurointerventional device market due to their versatility and potential for customization. These materials are particularly used in the development of drug-eluting stents and bioresorbable devices, which can provide targeted therapeutic benefits while minimizing the risk of complications. The growing interest in minimally invasive techniques is driving the demand for polymer-based neurointerventional devices, as they can be designed to offer superior flexibility and conformability. Moreover, the increasing focus on patient-centered care and the desire for improved outcomes are prompting healthcare providers to explore the potential of polymer materials in neurointerventional applications.

Bioresorbable:

Bioresorbable materials represent an innovative advancement in the neurointerventional device market, as they naturally dissolve over time after fulfilling their purpose. This technology eliminates the need for permanent implants, reducing the risk of long-term complications associated with traditional metallic devices. The adoption of bioresorbable neurointerventional devices is on the rise, particularly in applications like drug delivery and vascular support. As the focus on patient safety and comfort increases, bioresorbable materials are becoming a preferred choice for healthcare providers. Furthermore, ongoing research and development in this area are expected to lead to the introduction of more advanced bioresorbable devices, further driving market growth.

By Region

The North American region is currently the largest market for neurointerventional devices, accounting for approximately 40% of the global market share in 2023. Factors contributing to this dominance include the high prevalence of neurological disorders, advanced healthcare infrastructure, and significant investments in research and development. The United States, in particular, is a leader in the adoption of advanced neurointerventional techniques, driven by a growing number of specialized centers and an increasing focus on minimally invasive procedures. Additionally, the supportive regulatory environment and favorable reimbursement policies in this region are further propelling the market growth, with a projected CAGR of 8.0% through 2035. As healthcare providers continue to invest in cutting-edge technologies and patient care, North America is expected to maintain its leading position in the neurointerventional device market.

Europe holds the second-largest share of the neurointerventional device market, accounting for around 30% of the global market in 2023. The region is experiencing significant growth due to the rising prevalence of neurovascular diseases, increased healthcare expenditure, and advancements in medical technology. Countries such as Germany, France, and the United Kingdom are at the forefront of adopting innovative neurointerventional solutions, driven by a growing emphasis on improving patient outcomes and reducing hospitalization times. Furthermore, ongoing collaborations between medical device manufacturers and healthcare providers are facilitating the development of new and advanced products in this region. Asia Pacific is also emerging as a lucrative market, with a projected CAGR of 9.5%, driven by increasing investments in healthcare infrastructure, a growing geriatric population, and rising awareness of neurovascular conditions.

Opportunities

The neurointerventional device market presents numerous opportunities for growth and innovation, primarily driven by advancements in technology and increasing demand for minimally invasive procedures. One of the key areas of opportunity lies in the development of next-generation devices that offer improved safety and efficacy. Manufacturers can focus on integrating artificial intelligence (AI) and machine learning (ML) into neurointerventional devices, enhancing their ability to assist in complex procedures and reducing the risk of complications. Furthermore, as telemedicine continues to gain traction, there is potential for remote monitoring and consultation services to enhance patient access to neurointerventional therapies. This can lead to better patient outcomes and increased adoption of neurointerventional devices, especially in underserved regions where access to specialized care is limited. Additionally, partnerships between medical device manufacturers and healthcare providers are likely to yield innovative solutions tailored to meet the evolving needs of patients and practitioners.

Another significant opportunity in the neurointerventional device market is the expansion into emerging markets, particularly in Asia Pacific and Latin America. As these regions experience economic growth and improvements in healthcare infrastructure, the demand for advanced neurointerventional technologies is expected to rise. Companies that strategically position themselves to address the unique challenges and needs of these markets can gain a competitive advantage. Moreover, the increasing focus on preventive healthcare and early intervention is leading to a greater emphasis on education and awareness regarding neurovascular diseases. Manufacturers that invest in educational initiatives and collaborate with healthcare professionals to disseminate knowledge about neurointerventional therapies can drive market growth. Overall, the neurointerventional device market is poised for significant expansion, driven by technological advancements, strategic partnerships, and a commitment to improving patient outcomes.

Threats

While the neurointerventional device market presents numerous growth opportunities, it is not without its threats that could potentially hinder progress. One of the most significant threats is the stringent regulatory environment surrounding medical devices, which can result in lengthy approval processes and increased costs for manufacturers. The complexity of obtaining regulatory approvals across different regions can pose challenges for companies looking to introduce innovative products to the market. Additionally, the rising costs associated with research and development, as well as the need for extensive clinical trials, can create financial strain on manufacturers, particularly smaller companies. Furthermore, the increasing prevalence of alternative treatment options, including conservative management strategies and pharmacological therapies, could impact the demand for neurointerventional devices. As healthcare providers weigh the risks and benefits of various treatment modalities, the market for neurointerventional devices may face increased competition from these alternatives.

Another potential threat to the neurointerventional device market lies in the evolving landscape of healthcare reimbursement policies. Changes in reimbursement structures and guidelines can significantly influence the adoption of neurointerventional therapies. If insurance coverage for these procedures becomes limited or less favorable, it may deter healthcare providers from utilizing advanced neurointerventional devices. Additionally, economic downturns or fluctuations in healthcare spending could also impact the purchasing decisions of hospitals and clinics, leading to reduced demand for these devices. Manufacturers must remain vigilant and adaptable in the face of these potential threats, focusing on robust regulatory strategies and demonstrating the cost-effectiveness and clinical benefits of their products to ensure continued market growth.

Competitor Outlook

• Medtronic
• Stryker Corporation
• Penumbra, Inc.
• Terumo Corporation
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• MicroVention, Inc.
• Neuravi Ltd.
• Cook Medical
• Asahi Intecc Co., Ltd.
• Abbott Laboratories
• Getinge AB
• Cardinal Health, Inc.
• Balt Extrusion
• AngioDynamics, Inc.

The competitive landscape of the neurointerventional device market is characterized by the presence of numerous key players, each striving to innovate and expand their product offerings. Medtronic and Stryker Corporation are among the leading companies, known for their comprehensive portfolios of neurointerventional devices that cater to various clinical needs. Medtronic, with its robust research and development capabilities, is continuously introducing advanced solutions aimed at improving treatment outcomes for patients with neurovascular conditions. Similarly, Stryker Corporation is recognized for its commitment to enhancing the safety and effectiveness of neurointerventional procedures through innovative technologies. Both companies are investing heavily in clinical studies to validate their product efficacy and drive market adoption.

Penumbra, Inc. is another prominent player in the neurointerventional device market, specializing in thrombectomy devices and other innovative solutions. Penumbra's focus on advancing technologies for stroke treatment has positioned it as a leader in the field, with a strong emphasis on improving patient outcomes. Terumo Corporation and Boston Scientific Corporation are also significant competitors, offering a range of neurointerventional products, including embolization coils and stents. These companies are actively expanding their market presence through strategic partnerships and acquisitions, enabling them to enhance their product portfolios and reach a wider customer base. The competitive dynamics in the neurointerventional device market are further intensified by the increasing number of startups and emerging companies entering the space, driving innovation and fostering healthy competition.

As the neurointerventional device market continues to evolve, key players are focusing on several strategies to maintain their competitive edge. Investment in research and development remains a top priority, as companies strive to introduce novel products that address unmet clinical needs. Collaboration with healthcare providers and academic institutions is another crucial strategy, enabling companies to leverage expertise and gain insights into emerging trends in neurointerventional therapies. Additionally, the emphasis on personalized medicine is driving companies to develop tailored solutions that cater to the unique needs of patients, further enhancing their market position. As the landscape becomes increasingly competitive, companies that can effectively navigate regulatory challenges, demonstrate clinical value, and foster strong relationships with healthcare professionals will be well-positioned for success in the neurointerventional device market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Getinge AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Neuravi Ltd.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Balt Extrusion
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Penumbra, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 MicroVention, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AngioDynamics, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Stryker Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Asahi Intecc Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Johnson & Johnson (Ethicon)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Neurointerventional Device Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Neurointerventional Device Market, By Product Type
    • 6.2.1 Embolization Coils
    • 6.2.2 Neurovascular Stents
    • 6.2.3 Microcatheters
    • 6.2.4 Flow Diverters
    • 6.2.5 Neurovascular Thrombectomy Devices
  • 6.3 Neurointerventional Device Market, By Material Type
    • 6.3.1 Metallic
    • 6.3.2 Polymer
    • 6.3.3 Bioresorbable
  • 6.4 Neurointerventional Device Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Neurointerventional Device Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Neurointerventional Device market is categorized based on

By Product Type

• Embolization Coils
• Neurovascular Stents
• Microcatheters
• Flow Diverters
• Neurovascular Thrombectomy Devices

By Application

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

By Material Type

• Metallic
• Polymer
• Bioresorbable

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Stryker Corporation
• Penumbra, Inc.
• Terumo Corporation
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• MicroVention, Inc.
• Neuravi Ltd.
• Cook Medical
• Asahi Intecc Co., Ltd.
• Abbott Laboratories
• Getinge AB
• Cardinal Health, Inc.
• Balt Extrusion
• AngioDynamics, Inc.